Baxter International Inc   (BAX)
Other Ticker:  
Price: $33.7800 $0.04 0.119%
Day's High: $33.83 Week Perf: 2.71 %
Day's Low: $ 33.41 30 Day Perf: -4.66 %
Volume (M): 4,085 52 Wk High: $ 50.21
Volume (M$): $ 138,001 52 Wk Avg: $39.23
Open: $33.56 52 Wk Low: $31.01

 Market Capitalization (Millions $) 17,228
 Shares Outstanding (Millions) 510
 Employees -
 Revenues (TTM) (Millions $) 14,756
 Net Income (TTM) (Millions $) 2,657
 Cash Flow (TTM) (Millions $) 1,353
 Capital Exp. (TTM) (Millions $) 702

Baxter International Inc
Baxter International Inc. is a global healthcare company that specializes in the development, manufacturing, and distribution of medical products and devices. The company offers a wide range of products, including pharmaceuticals, biotechnology therapies, and renal care solutions.

Baxter's products and therapies help treat various medical conditions, such as critical care, infectious diseases, kidney diseases, and immune disorders. The company is known for its innovative solutions that improve patient care and clinical outcomes.

Headquartered in Deerfield, Illinois, Baxter operates in over 100 countries and serves healthcare professionals and patients worldwide. The company has a strong focus on research and development, continuously investing in new technologies and therapies to address unmet medical needs.

Overall, Baxter International Inc. is committed to enhancing patient care, improving the quality of life, and advancing healthcare through its products and services.

   Company Address: One Baxter Parkway, Deerfield, 60015 IL
   Company Phone Number: 948.2000   Stock Exchange / Ticker: NYSE BAX

Customers Net Income grew by BAX's Customers Net Profit Margin grew to

178.29 %

5.92 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
BDX   -2.41%    
BIIB        2.53% 
HELE   -1.13%    
MRK   -1.53%    
PFE   -1.92%    
PLL   -7.42%    
• View Complete Report

Business Update

Baxter International Announces Ambitious New Venture Amidst Revenue Challenges

Published Wed, May 15 2024 8:39 PM UTC

Baxter International Announces Ambitious New Venture Amidst Revenue ChallengesIn an exciting development, Baxter International Inc. (NYSE:BAX), a global leader in medical technology, announced the mission and logo for its newly proposed kidney care and acute therapies company, Vantive. Amidst challenging financial metrics for Q1, this strategic venture is part of Baxter?s o...

Business Update

Baxter International Expands Clinolipid Indication for Pediatric Patients, Records Steady Sales Growth amidst Challenging Market Conditions

Published Mon, May 13 2024 1:47 PM UTC

Baxter International Inc. has recently received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication of its proprietary product, Clinolipid (Lipid Injectable Emulsion), in pediatric patients. This includes both preterm and term neonates, making Baxter a frontrunner in providing essential nutrition therapy for infants when oral or enteral nutri...

Baxter International Inc

Baxter International Inc Sees Income per Share Decline by -22.22% in Q1 of 2024

Baxter International Inc, a global medtech leader, recently reported its financial results for the fourth quarter and full year of 2023, as well as provided guidance for the full-year and first-quarter of 2024. The company's performance in 2023 was underpinned by strategic initiatives aimed at enhancing future performance, such as the implementation of a new operating model and the sale of its BioPharma Solutions business.
In a bid to further solidify its position as a sustainable healthcare provider, Baxter International Inc embarked on a groundbreaking pilot program in collaboration with Northwestern Medicine. The program focused on recycling PVC IV bag waste, a milestone achievement that saw over six tons of waste recycled ? a significant step forward in reducing healthcare-related environmental impact.

Baxter International Inc

BAX Reports Surprising Top-line Decline, Initiates Bold Strategies to Bounce Back Strong in Q4 2023

Baxter International Inc, a global medtech leader, recently reported its financial results for the fiscal fourth quarter of 2023, showcasing both successes and challenges in its operations. Despite facing soft demand during this period, the company managed to improve its earnings per share, with a notable increase in profit per share. Revenue, however, saw a decline year on year, which was not on par with the performance of the Medical Equipment & Supplies industry as a whole.
In the fiscal fourth quarter of 2023, Baxter International Inc reported a 34.83% jump in profit per share to $0.48, while revenue sank by -3.55% to $3.75 billion. Net profits also saw an increase of 32.97% from the previous year. Despite a decrease in revenue, the company's net margin actually improved to 6.56%.

Product Service News

Baxter International Inc.: Revolutionizing Healthcare Waste Management With IV Bag Recycling Program, A Pioneer in Sustainability and Financial Growth

Published Thu, Dec 14 2023 1:00 PM UTC

Baxter International Inc. Makes Strides in Sustainable Healthcare Practices While Maintaining Financial Growth
In a groundbreaking pilot program, Baxter International Inc. has taken a significant step towards reducing the environmental impact of healthcare waste. The company, known for its innovative infusion therapies and technologies, partnered with Northwestern Medici...


Baxter International Inc's Segments
• View Complete Report
  Company Estimates  
  Revenue Outlook
Baxter International Inc does not provide revenue guidance.

Earnings Outlook
Baxter International Inc does not provide earnings estimates.

Geographic Revenue Dispersion


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com